CannaPharmaRX, Inc.
CPMD
$0.0044
-$0.0001-2.22%
OTC PK
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 54.42% | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 54.42% | -- | |||
| Cost of Revenue | 228.42% | -- | |||
| Gross Profit | -380.80% | -- | |||
| SG&A Expenses | -210.23% | -49.77% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 147.15% | 133.73% | |||
| Operating Income | -205.30% | -43.65% | |||
| Income Before Tax | -2,085.56% | -96.49% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -2,085.56% | -96.49% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -2,085.56% | -96.49% | |||
| EBIT | -205.30% | -43.65% | |||
| EBITDA | -243.12% | -53.63% | |||
| EPS Basic | -1,966.67% | -96.30% | |||
| Normalized Basic EPS | -1,850.00% | -96.97% | |||
| EPS Diluted | -1,966.67% | -96.30% | |||
| Normalized Diluted EPS | -1,850.00% | -96.97% | |||
| Average Basic Shares Outstanding | 0.04% | 0.69% | |||
| Average Diluted Shares Outstanding | 0.04% | 0.69% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||